Hamner Institute for Health Sciences

Considering the widespread use of the cell line, these findings could have significant implications for the research community. 

NEW YORK (GenomeWeb News) – The Hamner Institutes for Health Sciences has established a pre-competitive partnership with several organizations to advance an integrated systems biology approach to toxicity testing research.

The grant to two North Carolina scientists will support using the mouse models for human adverse reaction research.

People in the News

Qiang Zhang has been named director of the Hamner Center for Dose Response Modeling, and Christopher Ahlberg joined Fina Technologies' board of directors.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.